News

WESTON, Fla., May 27, 2025 /PRNewswire/ - Apotex Corp. today announced the launch of nilotinib capsules, a generic version of Tasigna®, in the United States, with 180 days of exclusivity.
Here’s a list of movies now playing at Capitol Cinema 16 in Cheyenne. Summaries provided by IMDB. "The Accountant 2" (R) Christian Wolff applies his brilliant mind and illegal methods to ...
When it’s brands, brands, brands, all the way down, they start feeling simply generic: nothing special about them. When you buy a book using a link on this page, we receive a commission.
LARGEST MARGIN OF VICTORY 16 (def. West Memphis 16-0 on March 19) LARGEST MARGIN OF DEFEAT 3 (lost to Conway 5-2 on March 21, lost to Kansas City (Mo.) Staley 7-4 on March 29, lost to Rogers 5-2 ...
YOKOTA AIR BASE, Japan — A brick-sized cellphone, a Pokemon card and a purple Teletubbies toy were among the items pulled from a pair of time capsules buried a quarter-century ago in a ...
May 7 (Reuters) - The U.S. Patent and Trademark Office has refused Tesla's (TSLA.O), opens new tab attempt to trademark the term "Robotaxi" in reference to its vehicles, TechCrunch reported on ...
Is there anything as dependable as the slasher formula? It waxes, wanes and winks its way through cultural cycles but it endures; malleable yet sturdy, high or lowbrow (usually low), requiring ...
Joy Organics offers these broad-spectrum CBD capsules in three potency options: 10, 25, and 100 milligrams (mg). The 10 mg per serving product may suit those new to CBD, while the 25- and 100-mg ...
Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for an abbreviated new drug application for Ticagrelor Tablets 90 mg and tentative approval for Ticagrelor ...
Tesla’s attempt to trademark the term “Robotaxi” in reference to its vehicles has been refused by the U.S. Patent and Trademark Office for being too generic, according to a new filing.
Dates: Quarterfinals, Wednesday and Thursday; Semifinals, May 27; Final, May 29 at Scranton High School at 5 p.m. Advance to states: 1. Defending champion: Delaware ...
Takeda is hoping that the boosts to come will help it shake off the ghost of its Vyvanse past, its longtime top-selling ADHD med that succumbed to generic competition in late 2023 after 16 years ...